|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,310,000,000 |
Market
Cap: |
72.25(B) |
Last
Volume: |
37,878,742 |
Avg
Vol: |
7,586,944 |
52
Week Range: |
$65.17 - $81.42 |
|
Level
I Sector: |
Consumer Discretionary |
Level
II Sector: |
Retail |
Level
III Sector: |
Drug Stores |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : 7.4 |
Insider 3/6 Months : 8 |
|
Guru Rank Number : 214 |
Guru Rank Value : 5.7 |
Guru Occurances : 5 |
|
|
|
|
|
|
|
Company Profile CVS Health is a health solutions company. Co.'s segments include:Health Care Benefits, which provides voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, and dental and behavioral health plans; Pharmacy Services, which provides pharmacy benefit management solutions, including plan design offerings and administration, formulary management, and retail pharmacy network management services; and Retail/Long-Term Care (LTC), which sells prescription drugs and various health and wellness products and general merchandise, provides health care services through its MinuteClinic® walk-in medical clinics and conducts LTC pharmacy operations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
2,000 |
16,000 |
16,000 |
Total Buy Value |
$0 |
$140,930 |
$1,117,497 |
$1,117,497 |
Total People Bought |
0 |
1 |
2 |
2 |
Total Buy Transactions |
0 |
1 |
2 |
2 |
Total Shares Sold |
29,473 |
29,473 |
55,232 |
484,338 |
Total Sell Value |
$2,267,947 |
$2,267,947 |
$4,197,951 |
$46,038,227 |
Total People Sold |
1 |
1 |
2 |
5 |
Total Sell Transactions |
1 |
1 |
2 |
7 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
White Tony L |
Director |
|
2021-05-13 |
4 |
A |
$84.27 |
$121,854 |
D/D |
1,446 |
36,500 |
|
- |
|
Finucane Anne A. |
Director |
|
2021-05-13 |
4 |
A |
$84.27 |
$121,854 |
D/D |
1,446 |
1,446 |
|
- |
|
Dorman David W |
Director |
|
2021-05-13 |
4 |
A |
$84.27 |
$292,417 |
D/D |
3,470 |
106,670 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2021-05-10 |
4 |
AS |
$86.00 |
$9,414,334 |
D/D |
(109,469) |
0 |
|
-0% |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2021-05-10 |
4 |
OE |
$62.21 |
$6,810,066 |
D/D |
109,469 |
109,469 |
|
- |
|
Brennan Troyen A |
EVP and Chief Medical Officer |
|
2021-05-07 |
4 |
AS |
$84.00 |
$796,068 |
D/D |
(9,477) |
144,697 |
|
0% |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2021-05-04 |
4 |
OE |
$58.34 |
$2,874,937 |
D/D |
49,279 |
49,279 |
|
- |
|
Boratto Eva C |
EVP & CFO |
|
2021-05-04 |
4 |
AS |
$80.00 |
$392,400 |
D/D |
(4,905) |
115,331 |
|
4% |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2021-04-21 |
4 |
AS |
$77.00 |
$7,963,571 |
D/D |
(103,423) |
0 |
|
10% |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2021-04-21 |
4 |
OE |
$54.19 |
$5,473,353 |
D/D |
101,003 |
103,423 |
|
- |
|
Boratto Eva C |
EVP & CFO |
|
2021-04-01 |
4 |
D |
$74.30 |
$3,029,731 |
D/D |
(40,777) |
120,236 |
|
- |
|
Brennan Troyen A |
EVP and Chief Medical Officer |
|
2021-04-01 |
4 |
D |
$74.30 |
$3,304,715 |
D/D |
(44,478) |
154,174 |
|
- |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2021-04-01 |
4 |
A |
$74.30 |
$349,953 |
D/D |
4,710 |
18,046 |
|
- |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2021-04-01 |
4 |
D |
$74.30 |
$501,451 |
D/D |
(6,749) |
16,920 |
|
- |
|
Merlo Larry J |
Director |
|
2021-04-01 |
4 |
D |
$0.00 |
$6,070,310 |
D/D |
(90,351) |
632,947 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2021-04-01 |
4 |
D |
$74.30 |
$4,713,964 |
D/D |
(63,445) |
65,373 |
|
- |
|
Rohan Karen |
EVP and President, Aetna |
|
2021-04-01 |
4 |
D |
$74.30 |
$3,210,577 |
D/D |
(43,211) |
52,091 |
|
- |
|
Roberts Jonathan C |
EVP & Chief Operating Officer |
|
2021-04-01 |
4 |
D |
$74.30 |
$5,922,750 |
D/D |
(79,714) |
96,761 |
|
- |
|
Bisaccia Lisa |
Former EVP & Chief HR Officer |
|
2021-04-01 |
4 |
D |
$74.30 |
$2,697,833 |
D/D |
(36,310) |
66,417 |
|
- |
|
Lotvin Alan |
EVP&President-PharmacyServices |
|
2021-04-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,431) |
61,691 |
|
- |
|
Finke Daniel P |
EVP/Pres, Health Care Benefits |
|
2021-04-01 |
4 |
D |
$74.30 |
$786,391 |
D/D |
(10,584) |
28,565 |
|
- |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2021-03-31 |
4 |
AS |
$76.00 |
$406,600 |
D/D |
(5,350) |
7,244 |
|
11% |
|
Clark James David |
SVP, Cont & Chief Acct Officer |
|
2021-03-31 |
4 |
OE |
$74.29 |
$397,452 |
D/D |
5,350 |
12,594 |
|
- |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2021-03-29 |
4 |
AS |
$76.15 |
$4,793,109 |
D/D |
(62,943) |
0 |
|
6% |
|
Moriarty Thomas M |
EVP & General Counsel |
|
2021-03-29 |
4 |
OE |
$74.29 |
$4,676,035 |
D/D |
62,943 |
62,943 |
|
- |
|
711 Records found
|
|
Page 8 of 29 |
|
|